Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.000
+0.250 (6.67%)
At close: Jun 26, 2026, 4:00 PM EDT
3.980
-0.020 (-0.50%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Elicio Therapeutics Employees
Elicio Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
n/a
Profits / Employee
-$1,217,727
Market Cap
76.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Heron Therapeutics | 128 |
| MindWalk Holdings | 102 |
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Entera Bio | 22 |
| Gain Therapeutics | 21 |
| iBio, Inc. | 20 |
ELTX News
- 3 days ago - Elicio Therapeutics Transcript: KOL event - Transcripts
- 9 days ago - Elicio Therapeutics assumed with a Buy at Ladenburg - TheFly
- 10 days ago - Elicio Therapeutics reports complete responses in pancreatic cancer trial - TheFly
- 10 days ago - Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer - GlobeNewsWire
- 11 days ago - Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX) - PRNewsWire
- 12 days ago - Elicio Therapeutics downgraded to Hold from Buy at JonesResearch - TheFly
- 12 days ago - Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal - Reuters
- 12 days ago - Elicio selloff brings attractive entry point, says H.C. Wainwright - TheFly